Nymox Pharmaceutical Corporation news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

NYMX 0.470 +0.005 (1.08%)
price chart
EQUITY ALERT: Rosen Law Firm Reminds Nymox Pharmaceutical Corporation ...
NEW YORK, Dec. 12, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds purchasers of Nymox Pharmaceutical Corporation common stock (Nasdaq:NYMX) during the period from January 31, 2011 through November 2, 2014, of the important ...
Related articles »  
Here's Why Nymox Nosedived Yesterday
Nymox Pharmaceutical Corporation (NYMX) was one of the biggest losers in the biotech sector yesterday, as its stock plunged almost 82% on news that the company's key drug candidate was unsuccessful in two late-stage trials.
Nymox Pharmaceutical Corp. (NYMX) Plunged To A New Low After Study Failed  RTT News
Nymox NX-1207 BPH Pivotal Phase 3 U.S. Studies NX02-0017 and NX02-0018 ...  GlobeNewswire (press release)
Related articles »  
Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation ...
PHILADELPHIA, Nov. 26, 2014 /PRNewswire/ -- Cohen, Placitella & Roth, PC is investigating potential claims on behalf of investors who purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") NYMX, -3.62% during the period from January ...
Related articles »  
Class Action Lawsuit Filed Against Nymox Pharmaceutical Corporation and Paul ...
PHILADELPHIA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Law Offices Bernard M. Gross, P.C. filed a class action lawsuit in the United States District Court, District of New Jersey, 14-cv-07331, on behalf of purchasers of NYMOX common stock between January ...
Related articles »  
Investor Alert: Lawsuit against Nymox Pharmaceutical Corporation (NASDAQ ...
The Shareholders Foundation announces that an investor, who purchased shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX), filed a lawsuit in the U.S.
NASDAQ:NYMX Investor Alert: Lawsuit against Nymox Pharmaceutical ...
An investor, who purchased shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX), filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Nymox Pharmaceutical Corporation in ...
Nymox Reports Third Quarter 2014 Financial Results
HASBROUCK HEIGHTS, N.J., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today its financial results for the third quarter of 2014.
Related articles »  
Encouraging trial results for Nymox prostate cancer drug candidate (NYMX)
In an analysis of clinical outcomes at eight months in a 146-patient Phase 2 clinical trial evaluating the safety and efficacy of Nymox's (NYMX +3.9%) drug candidate for low grade localized prostate cancer, NX-1207, the proportion of patients who ...
Nymox Announces Positive Prostate Cancer 8 Month Clinical Trial Results  GlobeNewswire (press release)
Related articles »  
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class ...
11, 2014 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Nymox Pharmaceutical Corporation ...
Related articles »  
Nymox Reports Second Quarter 2014 Financial Results
HASBROUCK HEIGHTS, N.J., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today its financial results for the second quarter of 2014.
Related articles »